Literature DB >> 27826144

Screening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferi.

Venkata Raveendra Pothineni1, Dhananjay Wagh1, Mustafeez Mujtaba Babar1, Mohammed Inayathullah1, R Edward Watts1, Kwang-Min Kim1, Mansi B Parekh1, Abhijit Achyut Gurjarpadhye1, David Solow-Cordero2, Lobat Tayebi3, Jayakumar Rajadas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27826144     DOI： 10.1038/ja.2016.131

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  23 in total

1.  Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

Authors:  Linda K Bockenstedt; David G Gonzalez; Ann M Haberman; Alexia A Belperron
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

2.  The streptogramin antibiotics: update on their mechanism of action.

Authors:  D Beyer; K Pepper
Journal:  Expert Opin Investig Drugs       Date:  1998-04       Impact factor: 6.206

Review 3.  Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes.

Authors:  Justin D Radolf; Melissa J Caimano; Brian Stevenson; Linden T Hu
Journal:  Nat Rev Microbiol       Date:  2012-01-09       Impact factor: 60.633

Review 4.  Lyme disease: diagnostic issues and controversies.

Authors:  Maria E Aguero-Rosenfeld; Gary P Wormser
Journal:  Expert Rev Mol Diagn       Date:  2014-12-08       Impact factor: 5.225

5.  Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.

Authors:  Tobias Dörr; Marin Vulić; Kim Lewis
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

6.  Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.

Authors:  Kenneth A Cornell; Shekerah Primus; Jorge A Martinez; Nikhat Parveen
Journal:  J Antimicrob Chemother       Date:  2009-04-17       Impact factor: 5.790

7.  Lyme disease testing by large commercial laboratories in the United States.

Authors:  Alison F Hinckley; Neeta P Connally; James I Meek; Barbara J Johnson; Melissa M Kemperman; Katherine A Feldman; Jennifer L White; Paul S Mead
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

8.  Persistence of Borrelia burgdorferi following antibiotic treatment in mice.

Authors:  Emir Hodzic; Sunlian Feng; Kevin Holden; Kimberly J Freet; Stephen W Barthold
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

9.  Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition.

Authors:  Dhananjay Wagh; Venkata Raveendra Pothineni; Mohammed Inayathullah; Song Liu; Kwang-Min Kim; Jayakumar Rajadas
Journal:  Drug Des Devel Ther       Date:  2015-02-11       Impact factor: 4.162

10.  Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library.

Authors:  Jie Feng; Ting Wang; Wanliang Shi; Shuo Zhang; David Sullivan; Paul G Auwaerter; Ying Zhang
Journal:  Emerg Microbes Infect       Date:  2014-07-02       Impact factor: 7.163
View more
  4 in total

1.  Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.

Authors:  Richard I Horowitz; Phyllis R Freeman
Journal:  Antibiotics (Basel)       Date:  2022-07-07

2.  Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.

Authors:  Venkata Raveendra Pothineni; Hari-Hara S K Potula; Aditya Ambati; Venkata Vamsee Aditya Mallajosyula; Brindha Sridharan; Mohammed Inayathullah; Mohamed Sohail Ahmed; Jayakumar Rajadas
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

3.  In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease.

Authors:  Venkata Raveendra Pothineni; Mansi B Parekh; Mustafeez Mujtaba Babar; Aditya Ambati; Peter Maguire; Mohammed Inayathullah; Kwang-Min Kim; Lobat Tayebi; Hari-Hara Sk Potula; Jayakumar Rajadas
Journal:  Drug Des Devel Ther       Date:  2018-09-11       Impact factor: 4.162

4.  A human secretome library screen reveals a role for Peptidoglycan Recognition Protein 1 in Lyme borreliosis.

Authors:  Akash Gupta; Gunjan Arora; Connor E Rosen; Zachary Kloos; Yongguo Cao; Jiri Cerny; Andaleeb Sajid; Dieuwertje Hoornstra; Maryna Golovchenko; Natalie Rudenko; Ulrike Munderloh; Joppe W Hovius; Carmen J Booth; Christine Jacobs-Wagner; Noah W Palm; Aaron M Ring; Erol Fikrig
Journal:  PLoS Pathog       Date:  2020-11-11       Impact factor: 6.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.